These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20421156)

  • 21. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical margin and breast recurrence after breast-conserving therapy.
    Horiguchi J; Iino Y; Takei H; Maemura M; Yokoe T; Niibe H; Yamakawa M; Nakajima T; Oyama T; Morishita Y
    Oncol Rep; 1999; 6(1):135-8. PubMed ID: 9864416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
    Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
    Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer].
    Souchon R; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter Bihl ML; Wenz F; Sauer R;
    Strahlenther Onkol; 2006 Aug; 182(8):429-30. PubMed ID: 16896587
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
    Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MR-mammography: current status and perspectives].
    Funke M; Fischer U; Grabbe E
    Aktuelle Radiol; 1996 May; 6(3):130-5. PubMed ID: 8679736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locally recurrent angiosarcoma after excision in a patient treated with breast-conserving therapy.
    Nambisan M; Elwood E; Mammolito D
    Am Surg; 2008 Dec; 74(12):1227-8. PubMed ID: 19097548
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy.
    Nixon AJ; Schnitt SJ; Gelman R; Gage I; Bornstein B; Hetelekidis S; Recht A; Silver B; Harris JR; Connolly JL
    Cancer; 1996 Oct; 78(7):1426-31. PubMed ID: 8839547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
    Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
    Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
    Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Kawanowa K; Inoue K; Tabei T
    Breast J; 2010; 16(2):127-33. PubMed ID: 20030655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
    Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
    Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Margin index: a new method for prediction of residual disease after breast-conserving surgery.
    Margenthaler JA; Gao F; Klimberg VS
    Ann Surg Oncol; 2010 Oct; 17(10):2696-701. PubMed ID: 20422459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast conservation therapy in the management of invasive and in situ carcinoma.
    Masko GB; Triedman SA; Brotman RL; Webber BM; Yu A
    R I Med; 1995 Sep; 78(9):246-9. PubMed ID: 7579719
    [No Abstract]   [Full Text] [Related]  

  • 39. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
    Ringberg A; Nordgren H; Thorstensson S; Idvall I; Garmo H; Granstrand B; Arnesson LG; Sandelin K; Wallgren A; Anderson H; Emdin S; Holmberg L
    Eur J Cancer; 2007 Jan; 43(2):291-8. PubMed ID: 17118648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of margin width on local control of ductal carcinoma in situ of the breast.
    Silverstein MJ; Lagios MD; Groshen S; Waisman JR; Lewinsky BS; Martino S; Gamagami P; Colburn WJ
    N Engl J Med; 1999 May; 340(19):1455-61. PubMed ID: 10320383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.